Intranasal Naloxone for Opioid Overdose

JAMA. 2024 Jan 16;331(3):250-251. doi: 10.1001/jama.2023.23248.
No abstract available

Plain language summary

This JAMA Insights describes indications for naloxone use in preventing opioid overdoses and benefits vs barriers to its availability following FDA approval of its availability without a prescription.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intranasal
  • Analgesics, Opioid / poisoning
  • Drug Overdose* / drug therapy
  • Humans
  • Naloxone* / administration & dosage
  • Naloxone* / therapeutic use
  • Narcotic Antagonists* / administration & dosage
  • Narcotic Antagonists* / therapeutic use
  • Opiate Overdose* / drug therapy
  • Opioid-Related Disorders / drug therapy

Substances

  • Analgesics, Opioid
  • Naloxone
  • Narcotic Antagonists